1. Home
  2. Labeler Index
  3. Redpharm Drug, Inc.
  4. 67296-0904
  5. NDC Package Code: 67296-0904-2 Amoxicillin And Clavulanate Potassium

NDC Package 67296-0904-2 Amoxicillin And Clavulanate Potassium

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67296-0904-2
Package Description:
14 TABLET, FILM COATED in 1 BOTTLE
Product Code:
67296-0904
Proprietary Name:
Amoxicillin And Clavulanate Potassium
Usage Information:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium tablets and other antibacterial drugs, amoxicillin and clavulanate potassium tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin and clavulanate potassium tablets are a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: 1.1 Lower Respiratory Tract Infections caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.1.2 Acute Bacterial Otitis Media caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.1.3 Sinusitis caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.1.4 Skin and Skin Structure Infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.1.5 Urinary Tract Infections caused by beta-lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.1.6 Limitations of Use When susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, amoxicillin and clavulanate potassium tablets should not be used.
11-Digit NDC Billing Format:
67296090402
NDC to RxNorm Crosswalk:
  • RxCUI: 562508 - amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet
  • RxCUI: 562508 - amoxicillin 875 MG / clavulanate 125 MG Oral Tablet
  • RxCUI: 562508 - amoxicillin (as amoxicillin trihydrate) 875 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet
    • Labeler Name:
    Redpharm Drug, Inc.
    Sample Package:
    No
    Start Marketing Date:
    01-01-2018
    Listing Expiration Date:
    12-31-2023
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    67296-0904-128 TABLET, FILM COATED in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67296-0904-2?

    The NDC Packaged Code 67296-0904-2 is assigned to a package of 14 tablet, film coated in 1 bottle of Amoxicillin And Clavulanate Potassium, labeled by Redpharm Drug, Inc.. The product's dosage form is and is administered via form.

    Is NDC 67296-0904 included in the NDC Directory?

    No, Amoxicillin And Clavulanate Potassium with product code 67296-0904 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Redpharm Drug, Inc. on January 01, 2018 and its listing in the NDC Directory is set to expire on December 31, 2023 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 67296-0904-2?

    The 11-digit format is 67296090402. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-167296-0904-25-4-267296-0904-02